Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanara MedTech is a medical technology company focused on developing and commercializing transformative technologies for the wound care and surgical markets. The company's primary focus is on improving patient outcomes and reducing healthcare costs through its portfolio of advanced products, including CellerateRX Surgical Powder and Gel, which are designed to promote healing in a variety of wound types. Sanara also offers products like BIAKŌS Antimicrobial Skin and Wound Cleanser, which targets microbial biofilms, and various biologic products for tissue repair. By providing a comprehensive suite of solutions for both chronic and acute wound management, Sanara MedTech serves clinicians across multiple care settings, including hospitals, wound care centers, and post-acute facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanaru Company.